These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 33223285)

  • 1. Celiprolol Treatment in Patients with Vascular Ehlers-Danlos Syndrome.
    Baderkhan H; Wanhainen A; Stenborg A; Stattin EL; Björck M
    Eur J Vasc Endovasc Surg; 2021 Feb; 61(2):326-331. PubMed ID: 33223285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Despite celiprolol therapy, patients with vascular Ehlers-Danlos syndrome remain at risk of vascular events: A 12-year experience in an Italian referral center.
    Buso G; Paini A; Agabiti-Rosei C; De Ciuceis C; Bertacchini F; Stassaldi D; Salvetti M; Ritelli M; Venturini M; Colombi M; Muiesan ML
    Vasc Med; 2024 Jun; 29(3):265-273. PubMed ID: 38102934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial.
    Ong KT; Perdu J; De Backer J; Bozec E; Collignon P; Emmerich J; Fauret AL; Fiessinger JN; Germain DP; Georgesco G; Hulot JS; De Paepe A; Plauchu H; Jeunemaitre X; Laurent S; Boutouyrie P
    Lancet; 2010 Oct; 376(9751):1476-84. PubMed ID: 20825986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular Ehlers-Danlos Syndrome: Long-Term Observational Study.
    Frank M; Adham S; Seigle S; Legrand A; Mirault T; Henneton P; Albuisson J; Denarié N; Mazzella JM; Mousseaux E; Messas E; Boutouyrie P; Jeunemaitre X
    J Am Coll Cardiol; 2019 Apr; 73(15):1948-1957. PubMed ID: 30999998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celiprolol but not losartan improves the biomechanical integrity of the aorta in a mouse model of vascular Ehlers-Danlos syndrome.
    Dubacher N; Münger J; Gorosabel MC; Crabb J; Ksiazek AA; Caspar SM; Bakker ENTP; van Bavel E; Ziegler U; Carrel T; Steinmann B; Zeisberger S; Meienberg J; Matyas G
    Cardiovasc Res; 2020 Feb; 116(2):457-465. PubMed ID: 31056650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multi-institutional experience in the aortic and arterial pathology in individuals with genetically confirmed vascular Ehlers-Danlos syndrome.
    Shalhub S; Byers PH; Hicks KL; Charlton-Ouw K; Zarkowsky D; Coleman DM; Davis FM; Regalado ES; De Caridi G; Weaver KN; Miller EM; Schermerhorn ML; Shean K; Oderich G; Ribeiro M; Nishikawa C; Behrendt CA; Debus ES; von Kodolitsch Y; Powell RJ; Pepin M; Milewicz DM; Lawrence PF; Woo K
    J Vasc Surg; 2019 Nov; 70(5):1543-1554. PubMed ID: 31126764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splenic artery pathology presentation, operative interventions, and outcomes in 88 patients with vascular Ehlers-Danlos syndrome.
    Shalhub S; Nkansah R; El-Ghazali A; Hillenbrand CJ; Vaidya SS; Schwarze U; Byers PH
    J Vasc Surg; 2023 Aug; 78(2):394-404. PubMed ID: 37068529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Not Available].
    Boutouyrie P
    Therapie; 2020 Apr; 75(2):175-181. PubMed ID: 32127191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multi-institutional experience in vascular Ehlers-Danlos syndrome diagnosis.
    Shalhub S; Byers PH; Hicks KL; Coleman DM; Davis FM; De Caridi G; Weaver KN; Miller EM; Schermerhorn ML; Shean K; Oderich G; Ribeiro M; Nishikawa C; Charlton-Ouw K; Behrendt CA; Debus ES; von Kodolitsch Y; Zarkowsky D; Powell RJ; Pepin M; Milewicz DM; Regalado ES; Lawrence PF; Woo K
    J Vasc Surg; 2020 Jan; 71(1):149-157. PubMed ID: 31353273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular Ehlers-Danlos Syndrome: A Comprehensive Natural History Study in a Dutch National Cohort of 142 Patients.
    Demirdas S; van den Bersselaar LM; Lechner R; Bos J; Alsters SIM; Baars MJH; Baas AF; Baysal Ö; van der Crabben SN; Dulfer E; Giesbertz NAA; Helderman-van den Enden ATJM; Hilhorst-Hofstee Y; Kempers MJE; Komdeur FL; Loeys B; Majoor-Krakauer D; Ockeloen CW; Overwater E; van Tintelen PJ; Voorendt M; de Waard V; Maugeri A; Brüggenwirth HT; van de Laar IMBH; Houweling AC
    Circ Genom Precis Med; 2024 Jun; 17(3):e003978. PubMed ID: 38623759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New treatment options for vascular Ehlers-Danlos syndrome].
    Björck M; Hägg A; Wanhainen A; Pigg MH; Bergqvist D
    Lakartidningen; 2013 Jul 17-Aug 6; 110(29-31):1354-5. PubMed ID: 23980448
    [No Abstract]   [Full Text] [Related]  

  • 12. Vascular Ehlers-Danlos Syndrome With a Novel Missense COL3A1 Mutation Present With Pulmonary Complications and Iliac Arterial Dissection.
    Gu G; Yang H; Cui L; Fu Y; Li F; Zhou Z; Zheng Y
    Vasc Endovascular Surg; 2018 Feb; 52(2):138-142. PubMed ID: 29216800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Celiprolol therapy for vascular Ehlers-Danlos syndrome.
    Brooke BS
    Lancet; 2010 Oct; 376(9751):1443-4. PubMed ID: 20825985
    [No Abstract]   [Full Text] [Related]  

  • 14. Vascular Ehlers-Danlos syndrome: pathophysiology, diagnosis, and prevention and treatment of its complications.
    Beridze N; Frishman WH
    Cardiol Rev; 2012; 20(1):4-7. PubMed ID: 22143279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular diagnosis in vascular Ehlers-Danlos syndrome predicts pattern of arterial involvement and outcomes.
    Shalhub S; Black JH; Cecchi AC; Xu Z; Griswold BF; Safi HJ; Milewicz DM; McDonnell NB
    J Vasc Surg; 2014 Jul; 60(1):160-9. PubMed ID: 24650746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular Ehlers-Danlos syndrome: can the beneficial effect of celiprolol be extrapolated to bisoprolol?
    Gorosabel MC; Dubacher N; Meienberg J; Matyas G
    Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(3):199-200. PubMed ID: 31693161
    [No Abstract]   [Full Text] [Related]  

  • 17. Vascular Ehlers-Danlos Syndrome: Pathological Variants, Recent Discoveries, and Theoretical Approaches.
    Assavarittirong C; Au TY; Nguyen PV; Mostowska A
    Cardiol Rev; 2022 Nov-Dec 01; 30(6):308-313. PubMed ID: 34560710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vascular Ehlers-Danlos syndrome].
    Perdu J; Boutouyrie P; Lahlou-Laforêt K; Khau Van Kien P; Denarié N; Mousseaux E; Sapoval M; Julia P; Zinzindohoué F; Touraine P; Dumez Y; Trystram D; Vignal-Clermont C; Gimenez-Roqueplo AP; Jeunemaitre X; Fiessinger JN
    Presse Med; 2006 Dec; 35(12 Pt 2):1864-75. PubMed ID: 17159712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Evidence and Future Perspectives in the Medical Management of Vascular Ehlers-Danlos Syndrome: Focus on Vascular Prevention.
    Buso G; Corvini F; Fusco EM; Messina M; Cherubini F; Laera N; Paini A; Salvetti M; De Ciuceis C; Ritelli M; Venturini M; Chiarelli N; Colombi M; Muiesan ML
    J Clin Med; 2024 Jul; 13(14):. PubMed ID: 39064294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous pneumothorax and hemothorax frequently precede the arterial and intestinal complications of vascular Ehlers-Danlos syndrome.
    Shalhub S; Neptune E; Sanchez DE; Dua A; Arellano N; McDonnell NB; Milewicz DM
    Am J Med Genet A; 2019 May; 179(5):797-802. PubMed ID: 30793832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.